Chronic Kidney Disease Trial, Recruiting (NCT06109493)

Chronic Kidney Disease Trial, Recruiting NCT06109493 Sponsor: Universidad Europea de Madrid Condition: Chronic Kidney Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06109493 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Chronic Kidney Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have chronic kidney disease and are currently receiving haemodialysis (a treatment that filters your blood using a machine)
You are over 18 years old
You have been on haemodialysis for at least 3 months
You have scored 14 or higher on a questionnaire called the HADS (Hospital Anxiety and Depression Scale), which measures levels of anxiety and depression

Who may not be able to join:

You have been diagnosed with a severe or long-term mental health condition, intellectual disability, cognitive impairment, or a condition that significantly limits your daily functioning
You are currently taking antidepressant medication
You do not have a sufficient understanding of Spanish
You are currently being cared for in an Advanced Chronic Kidney Disease Unit (a specialist unit for people in later stages of kidney disease — confirm with trial site)
You are currently receiving any other form of psychological therapy or treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Francisco Montesinos, Ph.D., Universidad Europea de Madrid

Phone: +34647413773

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06109493

Sponsor: Universidad Europea de Madrid

Phase: Not Applicable

Status: Recruiting

Condition: Chronic Kidney Disease

Trial contact: +34647413773

More information: https://clinicaltrials.gov/study/NCT06109493

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have chronic kidney disease and are currently receiving haemodialysis (a treatment that filters your blood using a machine)
You are over 18 years old
You have been on haemodialysis for at least 3 months
You have scored 14 or higher on a questionnaire called the HADS (Hospital Anxiety and Depression Scale), which measures levels of anxiety and depression

Who may not be able to join:

You have been diagnosed with a severe or long-term mental health condition, intellectual disability, cognitive impairment, or a condition that significantly limits your daily functioning
You are currently taking antidepressant medication
You do not have a sufficient understanding of Spanish
You are currently being cared for in an Advanced Chronic Kidney Disease Unit (a specialist unit for people in later stages of kidney disease — confirm with trial site)
You are currently receiving any other form of psychological therapy or treatment

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Universidad Europea de Madrid

Registry

ClinicalTrials.gov

Start date

1 November 2023

Est. completion

31 December 2025

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Change in emotional distress assessed through Hospital Anxiety and Depression Scale (HADS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov